Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Albuquerque › NPI 1982799375
Hospital

Lovelace Health System, LLC

Lovelace Health System, LLC was paid $57.71M by Medicaid between Jan 2018 and Dec 2024, across 303 billing codes. Its largest line is 99284, emergency room visit (serious) — 14% of everything it billed.

33Billing provider infoLOVELACE HEALTH SYSTEM, LLC
ALBUQUERQUE, NM 87109
33aNPI1982799375assigned 10/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$57.71M
24GClaims873,781
24DCodes billed303
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Mexico

Rank by total paid#3 of 24
Median peer was paid$20.13M
This provider vs. median2.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018159,127$10.14M
2019120,011$7.74M
202087,391$6.50M
2021111,810$7.38M
2022131,020$8.06M
2023142,241$9.67M
2024incomplete122,181$8.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 14% 37,243 34,589 $7.88M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.2% 19,761 18,756 $5.31M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.2% 26,936 25,203 $4.13M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.6% 6,174 5,991 $2.09M
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 3.2% 14,820 14,290 $1.83M
76819 Fetal biophysical profile; without non-stress testing 3.0% 15,708 11,198 $1.76M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 2.8% 20,528 17,809 $1.59M
76820 2.2% 15,995 11,169 $1.24M
59025 Fetal non-stress test 2.0% 9,317 7,339 $1.18M
76825 1.9% 3,248 3,140 $1.12M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.8% 20,431 8,440 $1.01M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.7% 3,261 3,197 $996K
291 more codes
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 16,948 $927K
58661 1.5% 425 $892K
80053 Comprehensive metabolic panel 1.5% 35,952 $892K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 1.5% 3,228 $853K
70450 Computed tomography, head or brain; without contrast material 1.4% 4,344 $798K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.2% 2,017 $716K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1.2% 7,986 $710K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.2% 19,481 $688K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1.2% 8,778 $679K
96375 Therapeutic injection; each additional sequential IV push 1.1% 12,858 $629K
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.1% 1,976 $616K
93976 1.0% 5,190 $598K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.0% 45,392 $579K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 14,045 $577K
96361 Intravenous infusion, hydration; each additional hour <1% 7,528 $576K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,873 $571K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 6,191 $564K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,196 $562K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,200 $552K
G0378 Hospital observation service, per hour <1% 1,143 $511K
93325 <1% 3,620 $467K
76830 Ultrasound, transvaginal <1% 4,762 $465K
76801 <1% 4,466 $465K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,991 $416K
64493 <1% 925 $324K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,070 $316K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,449 $292K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,874 $292K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,916 $280K
77063 Screening digital breast tomosynthesis, bilateral <1% 4,788 $268K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 915 $262K
71045 Radiologic examination, chest; single view <1% 6,457 $258K
84703 <1% 14,843 $251K
71046 Radiologic examination, chest; 2 views <1% 4,924 $244K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,310 $242K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,014 $238K
77066 Tomosynthesis, mammo <1% 1,708 $226K
76642 <1% 2,741 $223K
36415 Collection of venous blood by venipuncture <1% 52,292 $219K
87086 Culture, bacterial; quantitative colony count, urine <1% 12,658 $217K
87631 <1% 2,268 $208K
58571 <1% 85 $199K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 2,668 $192K
97162 <1% 3,172 $192K
83690 <1% 12,396 $191K
94664 <1% 1,992 $183K
64494 <1% 914 $180K
C9290 Injection, bupivacaine liposome, 1 mg <1% 624 $177K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,060 $174K
64635 <1% 436 $174K
76813 <1% 2,336 $167K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,613 $166K
64636 <1% 423 $155K
81001 <1% 20,113 $151K
71275 Computed tomographic angiography, chest, with contrast material <1% 523 $145K
73030 <1% 1,963 $144K
84702 <1% 5,176 $131K
72125 Computed tomography, cervical spine; without contrast material <1% 674 $129K
84484 <1% 7,497 $127K
76641 <1% 1,594 $127K
73130 <1% 2,196 $125K
73564 <1% 1,290 $119K
76536 <1% 1,161 $118K
76826 <1% 403 $117K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 5,625 $113K
91200 <1% 799 $111K
77065 Tomosynthesis, mammo <1% 996 $105K
73562 <1% 1,434 $103K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,028 $103K
87040 <1% 3,334 $100K
73610 <1% 1,314 $99K
93971 <1% 1,185 $99K
47563 <1% 42 $96K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,175 $93K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,684 $89K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,616 $89K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 728 $89K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,615 $89K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 282 $88K
80048 Basic metabolic panel (calcium, ionized) <1% 4,556 $87K
96376 <1% 2,935 $85K
73630 <1% 1,329 $82K
83605 <1% 3,184 $77K
J7120 Ringers lactate infusion, up to 1000 cc <1% 12,726 $76K
73110 <1% 1,326 $76K
64495 <1% 369 $71K
80076 <1% 2,752 $63K
97035 <1% 3,026 $58K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,168 $53K
82962 <1% 6,040 $51K
83735 <1% 4,433 $51K
86850 <1% 4,257 $50K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,439 $45K
82565 <1% 3,740 $42K
94760 <1% 2,404 $41K
19083 <1% 76 $39K
93017 <1% 221 $39K
87186 <1% 2,300 $39K
70486 <1% 197 $38K
72100 <1% 520 $38K
76775 <1% 423 $37K
83880 <1% 1,214 $37K
87077 <1% 2,899 $37K
86900 <1% 6,024 $37K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 112 $36K
84443 Thyroid stimulating hormone (TSH) <1% 1,640 $36K
J2704 Injection, propofol, 10 mg <1% 7,227 $36K
84112 <1% 1,112 $36K
85610 <1% 3,972 $36K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 117 $36K
81003 <1% 9,407 $35K
74018 <1% 640 $33K
87210 <1% 2,842 $32K
81002 <1% 9,494 $31K
76770 <1% 316 $31K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 220 $30K
86901 <1% 6,024 $30K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 81 $29K
64490 <1% 106 $28K
81025 <1% 3,648 $27K
82330 <1% 1,637 $26K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 64 $26K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 471 $25K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,151 $24K
85379 <1% 1,356 $23K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 534 $23K
83615 <1% 1,833 $23K
73502 <1% 443 $23K
80051 <1% 1,493 $22K
80305 <1% 2,003 $22K
84550 <1% 1,801 $21K
88307 <1% 87 $21K
77080 <1% 268 $21K
87634 <1% 456 $20K
85730 <1% 2,059 $20K
82570 <1% 1,661 $19K
84156 <1% 1,661 $19K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 38 $19K
64491 <1% 100 $18K
82947 <1% 1,537 $18K
84520 <1% 1,567 $17K
73080 <1% 310 $16K
97535 Self-care/home management training, each 15 minutes <1% 461 $16K
97161 <1% 402 $16K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 954 $14K
71250 <1% 77 $13K
97018 <1% 1,233 $12K
29125 <1% 106 $12K
73221 <1% 33 $12K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 469 $12K
97165 <1% 242 $12K
12001 <1% 129 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,059 $12K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,600 $11K
90715 <1% 1,081 $11K
72131 <1% 66 $11K
85027 <1% 1,463 $11K
94761 <1% 451 $10K
85014 <1% 1,965 $9K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,251 $9K
86780 <1% 499 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 511 $8K
A4648 Tissue marker, implantable, any type, each <1% 205 $8K
72110 <1% 79 $8K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 215 $8K
88342 <1% 130 $8K
87650 <1% 335 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,965 $8K
64492 <1% 50 $7K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 14 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,463 $7K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 116 $7K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 692 $7K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 14 $6K
10060 <1% 70 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 1,327 $6K
74022 <1% 82 $6K
86703 <1% 358 $6K
93970 <1% 41 $6K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 15 $5K
76870 <1% 50 $5K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 14 $5K
87632 <1% 20 $5K
86762 <1% 277 $5K
80143 <1% 435 $5K
82150 <1% 401 $5K
80179 <1% 431 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 24 $5K
87081 <1% 259 $4K
87340 <1% 286 $4K
43235 <1% 15 $4K
72040 <1% 57 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 361 $4K
87339 <1% 296 $4K
84439 <1% 233 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,570 $4K
86803 <1% 210 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,789 $3K
C1781 Mesh (implantable) <1% 44 $3K
76821 <1% 38 $3K
87522 Neg quan hep c or qual rna <1% 54 $3K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 77 $3K
99153 Mod sedat endo service >5yrs <1% 243 $3K
J3490 Unclassified drugs <1% 171 $3K
85007 <1% 536 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,652 $3K
64633 <1% 14 $3K
72050 <1% 28 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 777 $2K
73140 <1% 40 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,751 $2K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 65 $2K
A4615 Cannula, nasal <1% 6,165 $2K
80061 Lipid panel <1% 106 $2K
J1596 Injection, glycopyrrolate, 0.1 mg <1% 373 $2K
71101 <1% 24 $2K
82731 <1% 25 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,202 $2K
82550 <1% 178 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 1,164 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 531 $2K
86140 <1% 214 $2K
82553 <1% 109 $2K
73090 <1% 26 $1K
C9399 Unclassified drugs or biologicals <1% 55 $1K
74220 <1% 18 $1K
87070 <1% 121 $1K
C1769 Guide wire <1% 85 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,016 $1K
80074 <1% 24 $1K
84100 <1% 152 $1K
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 15 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 621 $1K
29515 <1% 19 $1K
72070 <1% 12 $1K
J2060 Injection, lorazepam, 2 mg <1% 808 $1K
73590 <1% 26 $999.73
J3475 Injection, magnesium sulfate, per 500 mg <1% 196 $930.83
A9270 Non-covered item or service <1% 1,718 $906.27
87205 <1% 135 $771.37
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 703 $769.10
C2617 Stent, non-coronary, temporary, without delivery system <1% 28 $756.14
97163 <1% 12 $737.95
85652 <1% 125 $700.15
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 258 $686.24
76377 <1% 12 $673.45
99156 <1% 24 $591.92
A9578 Injection, gadobenate dimeglumine (multihance multipack), per ml <1% 17 $583.22
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 64 $574.64
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 14 $567.84
J1790 Injection, droperidol, up to 5 mg <1% 452 $552.16
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 288 $466.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 150 $456.11
82272 <1% 108 $451.74
87075 <1% 42 $435.06
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 259 $337.89
97116 <1% 23 $325.39
82803 <1% 13 $318.86
J1650 Injection, enoxaparin sodium, 10 mg <1% 181 $309.12
84481 <1% 14 $295.20
82728 <1% 13 $228.53
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 490 $227.16
J1644 Injection, heparin sodium, per 1000 units <1% 127 $221.69
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 314 $201.05
36416 <1% 104 $196.61
J0687 Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg <1% 214 $193.55
82760 <1% 13 $177.76
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 204 $167.78
84450 <1% 21 $164.35
J8540 Dexamethasone, oral, 0.25 mg <1% 242 $161.21
85018 <1% 39 $157.51
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 49 $157.32
82977 <1% 14 $153.46
84460 <1% 21 $146.14
83550 <1% 12 $140.88
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 71 $130.24
83540 <1% 12 $112.48
99157 <1% 13 $81.74
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 79 $81.14
J1171 Injection, hydromorphone, 0.1 mg <1% 51 $79.36
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 29 $79.23
J3480 Injection, potassium chloride, per 2 meq <1% 16 $78.74
C9113 Injection, pantoprazole sodium, per vial <1% 40 $60.94
J1630 Injection, haloperidol, up to 5 mg <1% 30 $45.57
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 219 $35.87
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 17 $32.59
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 14 $25.08
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 13 $14.50
J2550 Injection, promethazine hcl, up to 50 mg <1% 14 $6.90
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 282 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 262 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPETROVICH, STEPHEN (SVP)
Parent organizationARDENT LEGACY HOLDINGS, LLC
Same official

Other billing entities under PETROVICH, STEPHEN

Full network →
ProviderLocationPaid
Lovelace Health System LLCAlbuquerque, NM$45.27M
Southwest Medical Associates, LLCAlbuquerque, NM$41.40M
Lovelace Health System, LLCAlbuquerque, NM$31.24M
Lovelace Health System LLCRoswell, NM$20.13M
Jacksonville Hospital LLCJacksonville, TX$9.41M
Henderson Hospital, LLCHenderson, TX$8.52M
Athens Hospital, LLCAthens, TX$8.32M
Etmc Physician Group INC.Tyler, TX$8.03M
Tyler Regional Hospital LLCTyler, TX$7.94M
Lovelace Unm Rehabilitation Hospital LLCAlbuquerque, NM$6.30M
Pocatello Hospital LLCPocatello, ID$6.11M
Jacksonville Hospital LLCJacksonville, TX$5.93M
Ahs Pryor Hospital, LLCPryor, OK$5.61M
Bsa Hospital LLCAmarillo, TX$4.96M
Pittsburg Hospital LLCPittsburg, TX$4.83M
Ahs Claremore Regional Hospital, LLC.Claremore, OK$4.81M
Ahs Henryetta Hospital LLCHenryetta, OK$4.27M
Pittsburg Hospital LLCPittsburg, TX$3.98M
Topeka Hospital, LLCTopeka, KS$3.94M
Ahs Pryor Hospital, LLCPryor, OK$3.76M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.